Hologic Gains CE Mark for Use of Saliva Samples with Its COVID-19 Test

Hologic has obtained a CE mark for the use of saliva samples with its Aptima COVID-19 assay.

The molecular diagnostic assay detects the genetic material of the SARS-CoV-2 coronavirus that causes COVID-19 infections.

Marlborough, Mass.-based Hologic, which mainly focuses on the detection and treatment of illness in women, developed the Covid-19 assay in response to the pandemic. The assay runs on the company’s automated Panther system.